CSL
- Biotech or pharma, therapeutic R&D
- Investment bank
- Investor (buy-side or sell-side research)
CSL (ASX:CSL; USOTC:CSLLY) is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}